USPTO serial 87077151
DELEVA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BULLOFF, TOBY ELLEN
- Law office
- TMO LAW OFFICE 119 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with DELEVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for VITAMINS that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for DRUGS that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of PATCHES that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of TABLETS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of CAPSULES that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of LIQUID DISPERSIONS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of PELLETS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of PARTICLES that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of POWDER that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of COATINGS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of GRANULES that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of INSERTS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of STENTS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of TUBE that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of ROD that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of FILMS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of SOLUTIONS that facilitate the delivery of pharmaceutical preparations; Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for CONTROLLED RELEASE OF DRUG; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Transdermal patches featuring VITAMINS FOR PROMOTING GOOD HEALTH | ACTIVE | — |
| 010 | Drug delivery systems; Implantable subcutaneous drug delivery devices sold empty | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 2, 2017 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 2, 2017 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 5, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 20, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 20, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 28, 2016 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 28, 2016 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 28, 2016 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 19, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 19, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 14, 2016 | ALIE | ASSIGNED TO LIE | — |
| Oct 4, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 24, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 23, 2016 | NWAP | NEW APPLICATION ENTERED | — |